Nantahala Capital Management’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
939,202
+3
| +0% | +$15 | 0.18% | 81 |
|
|
2025
Q1 | $5.4M | Sell |
939,199
-100,000
| -10% | -$575K | 0.21% | 55 |
|
|
2024
Q4 | $8.25M | Buy |
1,039,199
+757,163
| +268% | +$6.01M | 0.35% | 47 |
|
|
2024
Q3 | $1.15M | Hold |
282,036
| – | – | 0.06% | 95 |
|
|
2024
Q2 | $1.41M | Sell |
282,036
-51,523
| -15% | -$258K | 0.08% | 87 |
|
|
2024
Q1 | $8.64M | Sell |
333,559
-10,259
| -3% | -$266K | 0.49% | 33 |
|
|
2023
Q4 | $2.98M | Sell |
343,818
-3,236
| -0.9% | -$28.1K | 0.18% | 70 |
|
|
2023
Q3 | $2.98M | Buy |
347,054
+282,312
| +436% | +$2.43M | 0.26% | 63 |
|
|
2023
Q2 | $829K | Hold |
64,742
| – | – | 0.08% | 83 |
|
|
2023
Q1 | $1.36M | Hold |
64,742
| – | – | 0.1% | 77 |
|
|
2022
Q4 | $350K | Sell |
64,742
-6,312
| -9% | -$34.1K | 0.02% | 90 |
|
|
2022
Q3 | $419K | Sell |
71,054
-1,914
| -3% | -$11.3K | 0.03% | 85 |
|
|
2022
Q2 | $606K | Buy |
72,968
+8,905
| +14% | +$74K | 0.03% | 86 |
|
|
2022
Q1 | $826K | Sell |
64,063
-4,613
| -7% | -$59.5K | 0.04% | 87 |
|
|
2021
Q4 | $1.42M | Sell |
68,676
-1,324
| -2% | -$27.3K | 0.05% | 89 |
|
|
2021
Q3 | $1.98M | Buy |
+70,000
| New | +$1.98M | 0.06% | 85 |
|